Advertisement

Recent Advances in the Management of Acute Ischemic Stroke

  • Ahamad Hassan
Chapter
Part of the Competency-Based Critical Care book series (CBCC)

Key Points

  1. 1.

    Acute ischemic stroke is amenable to early intervention, either by influencing the events involved in initial ischemia and propagation of brain injury, or by secondary prevention.

     
  2. 2.

    Till date, there has been inertia on the part of the medical profession and public in recognizing that acute stroke is a potentially treatable emergency.

     
  3. 3.

    Improved education, together with better organization of stroke services is likely to improve the recovery from this potentially devastating condition.

     

Keywords

Acute Ischemic Stroke Decompressive Craniectomy Stroke Service Basilar Artery Occlusion Malignant Middle Cerebral Artery Infarction 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. Baird TA, Parsons MW, Phanh T, Butcher KS, Desmond PM, Tress BM, Colman PG, Chambers BR, Davis SM (2003) Persistent poststroke hyperglycemia is independently associated with infarct expansion and worse clinical outcome. Stroke 34:2208–2214CrossRefPubMedGoogle Scholar
  2. Berg-Dammer E, Felber SR, Henkes H, Nahser HC, Kuhne D (2000) Long-term outcome after local intra-arterial fibrinolysis of basilar artery thrombosis. Cerebrovasc Dis 10:183–188CrossRefPubMedGoogle Scholar
  3. Blanco M, Nombela F, Castellanos M, Rodriguez-Yáñez M, García-Gil M, Leira R, Lizasoain I, Serena J, Vivancos J, Moro MA, Dávalos A, Castillo J (2007) Statin treatment withdrawal in ischemic stroke: a controlled randomized study. Neurology 69:904–910CrossRefPubMedGoogle Scholar
  4. Bonita R (1992) Epidemiology of stroke. Lancet 339:342–344CrossRefPubMedGoogle Scholar
  5. Chen ZM, Sandercock P, Pan HC, Counsell C, Collins R, Liu LS, Xie JX, Warlow C, Peto R (2000) Indications for early aspirin use in acute ischemic stroke : A combined analysis of 40 000 randomized patients from the chinese acute stroke trial and the international stroke trial. On behalf of the CAST and IST collaborative groups. Stroke 31:1240–1249PubMedGoogle Scholar
  6. Clark WM, Wissman S, Albers GW, Jhamandas JH, Madden KP, Hamilton S (1999) Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke. JAMA 282:2019–2026CrossRefPubMedGoogle Scholar
  7. Clark WM, Albers GW, Madden KP, Hamilton S (2000) The rtPA (alteplase) 0- to 6-hour acute stroke trial, part A (A0276g): results of a double-blind, placebo-controlled, multicenter study. Thrombolytic therapy in acute ischemic stroke study investigators. Stroke 31:811–816PubMedGoogle Scholar
  8. Coull AJ, Lovett JK, Rothwell PM (2004) Population based study of early risk of stroke after transient ischemic attack or minor stroke: implications for public education and organisation of services. BMJ 328:326CrossRefPubMedGoogle Scholar
  9. Department of Health (2005) Reducing brain damage: Faster access to better stroke care. National Audit Office ReportGoogle Scholar
  10. Furlan M, Marchal G, Viader F, Derlon JM, Baron JC (1996) Spontaneous neurological recovery after stroke and the fate of the ischemic penumbra. Ann Neurol 40:216–226CrossRefPubMedGoogle Scholar
  11. Furlan A, Higashida R, Wechsler L, Gent M, Rowley H, Kase C, Pessin M, Ahuja A, Callahan F, Clark WM, Silver F, Rivera F (1999) Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in acute cerebral thromboembolism. JAMA 282:2003–2011CrossRefPubMedGoogle Scholar
  12. Georgiadis D, Schwarz S, Aschoff A, Schwab S (2002) Hemicraniectomy and moderate hypothermia in patients with severe ischemic stroke. Stroke 33:1584–1588CrossRefPubMedGoogle Scholar
  13. Gray CS, Hildreth AJ, Sandercock PA, O’Connell JE, Johnston DE, Cartlidge NE, Bamford JM, James OF, Alberti KG (2007) Glucose-potassium-insulin infusions in the management of post-stroke hyperglycaemia: the UK glucose insulin in stroke trial (GIST-UK). Lancet Neurol 6:397–406CrossRefPubMedGoogle Scholar
  14. Hacke W, Kaste M, Fieschi C, Toni D, Lesaffre E, von Kummer R, Boysen G, Bluhmki E, Hoxter G, Mahagne MH (1995) Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA 274:1017–1025CrossRefPubMedGoogle Scholar
  15. Hacke W, Kaste M, Fieschi C, von Kummer R, Davalos A, Meier D, Larrue V, Bluhmki E, Davis S, Donnan G, Schneider D, Diez-Tejedor E, Trouillas P (1998) Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischemic stroke (ECASS II). Second European-Australasian acute stroke study investigators. Lancet 352:1245–1251CrossRefPubMedGoogle Scholar
  16. Hacke W, Kaste M, Bogousslavsky J, Brainin M, Chamorro A, Lees K, Leys D, Kwiecinski H, Toni P, Langhorne P, Diener C, Hennerici M, Ferro J, Sivenius J, Gunnar N, Bath P, Olsen TS, Gugging M (2003) European stroke initiative recommendations for stroke management-update 2003. Cerebrovasc Dis 16:311–337CrossRefGoogle Scholar
  17. Hacke W, Donnan G, Fieschi C, Kaste M, von Kummer R, Broderick JP, Brott T, Frankel M, Grotta JC, Haley EC Jr, Kwiatkowski T, Levine SR, Lewandowski C, Lu M, Lyden P, Marler JR, Patel S, Tilley BC, Albers G, Bluhmki E, Wilhelm M, Hamilton S (2004) Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet 363:768–774CrossRefPubMedGoogle Scholar
  18. Hacke W, Albers G, Al Rawi Y, Bogousslavsky J, Davalos A, Eliasziw M, Fischer M, Furlan A, Kaste M, Lees KR, Soehngen M, Warach S (2005) The desmoteplase in acute ischemic stroke trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase. Stroke 36:66–73CrossRefPubMedGoogle Scholar
  19. Hajat C, Hajat S, Sharma P (2000) Effects of poststroke pyrexia on stroke outcome : a meta-analysis of studies in patients. Stroke 31:410–414PubMedGoogle Scholar
  20. Hakim AM (1987) The cerebral ischemic penumbra. Can J Neurol Sci 14:557–559PubMedGoogle Scholar
  21. Johnston SC, Rothwell PM, Nguyen-Huynh MN, Giles MF, Elkins JS, Bernstein AL, Sidney S (2007) Validation and refinement of scores to predict very early stroke risk after transient ischemic attack. Lancet 369:283–292CrossRefPubMedGoogle Scholar
  22. Kogure T, Kogure K (1997) Molecular and biochemical events within the brain subjected to cerebral ischemia (targets for therapeutical intervention). Clin Neurosci 4:179–183PubMedGoogle Scholar
  23. Langhorne P, Tong BL, Stott DJ (2000) Association between physiological homeostasis and early recovery after stroke. Stroke 31:2518–2519PubMedGoogle Scholar
  24. Lovett JK, Dennis MS, Sandercock PA, Bamford J, Warlow CP, Rothwell PM (2003) Very early risk of stroke after a first transient ischemic attack. Stroke 34:e138–e140CrossRefGoogle Scholar
  25. Lovett JK, Coull AJ, Rothwell PM (2004) Early risk of recurrence by subtype of ischemic stroke in population-based incidence studies. Neurology 62:569–573PubMedGoogle Scholar
  26. Muir KW, Lees KR, Ford I, Davis S (2004) Intravenous Magnesium Efficacy in Stroke (IMAGES) Study Investigators. Magnesium for acute stroke (Intravenous Magnesium Efficacy in Stroke trial): randomised controlled trial. Lancet 363:439–445CrossRefPubMedGoogle Scholar
  27. Nadeau JO, Shi S, Fang J, Kapral MK, Richards JA, Silver FL, Hill MD (2005) TPA use for stroke in the Registry of the Canadian stroke network. Can J Neurol Sci 32:433–439PubMedGoogle Scholar
  28. Rothwell PM, Eliasziw M, Gutnikov SA, Warlow CP, Barnett HJ (2004) Endarterectomy for symptomatic carotid stenosis in relation to clinical subgroups and timing of surgery. Lancet 363:915–924CrossRefPubMedGoogle Scholar
  29. Rothwell PM, Giles MF, Chandratheva A, Marquardt L, Geraghty O, Redgrave JN, Lovelock CE, Binney LE, Bull LM, Cuthbertson FC, Welch SJ, Bosch S, Alexander FC, Silver LE, Gutnikov SA, Mehta Z (2007) Early use of Existing Preventive Strategies for Stroke (EXPRESS) study. Effect of urgent treatment of transient ischemic attack and minor stroke on early recurrent stroke (EXPRESS study): a prospective population-based sequential comparison. Lancet 370:1432–1442CrossRefPubMedGoogle Scholar
  30. Schrader J, Luders S, Kulschewski A, Berger J, Zidek W, Treib J, Einhaupl K, Diener HC, Dominiak P (2003) The ACCESS Study: evaluation of Acute Candesartan Cilexetil therapy in stroke survivors. Stroke 34:1699–1703CrossRefPubMedGoogle Scholar
  31. Shuaib A, Lees KR, Lyden P, Grotta J, Davalos A, Davis SM, Diener HC, Ashwood T, Wasiewski WW, Emeribe U (2007) SAINT II Trial Investigators. NXY-059 for the treatment of acute ischemic stroke. N Engl J Med 357:562–571CrossRefPubMedGoogle Scholar
  32. Steiner T, Mendoza G, De Georgia M, Schellinger P, Holle R, Hacke W (1997) Prognosis of stroke patients requiring mechanical ventilation in a neurological critical care unit. Stroke 28:711–715PubMedGoogle Scholar
  33. Stroke Unit Trialists’ Collaboration (2000) Organised inpatient (stroke unit) care for stroke. Cochrane Database Syst Rev 2:CD000197Google Scholar
  34. Sulter G, Elting JW, Langedijk M, Maurits NM, De Keyser J (2003) Admitting acute ischemic stroke patients to a stroke care monitoring unit versus a conventional stroke unit: a randomized pilot study. Stroke 34:101–104CrossRefPubMedGoogle Scholar
  35. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group (1995) Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 333:1581–1587CrossRefGoogle Scholar
  36. Vahedi K, Hofmeijer J, Juettler E, Vicaut E, George B, Algra A, Amelink GJ, Schmiedeck P, Schwab S, Rothwell PM, Bousser MG, van der Worp HB, Hacke W, DECIMAL, DESTINY, and HAMLET investigators (2007) Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomised controlled trials. Lancet Neurol 6:215–222.Google Scholar
  37. Wahlgren N, Ahmed N, Dávalos A, Ford GA, Grond M, Hacke W, Hennerici MG, Kaste M, Kuelkens S, Larrue V, Lees KR, Roine RO, Soinne L, Toni D, Vanhooren G, SITS-MOST investigators (2007) Thrombolysis with alteplase for acute ischemic stroke in the Safe Implementation of thrombolysis in stroke-monitoring study (SITS-MOST): an observational study. Lancet 369:275-282Google Scholar

Copyright information

© Springer-Verlag London Limited 2010

Authors and Affiliations

  • Ahamad Hassan
    • 1
  1. 1.Department of NeurologyLeeds General Infirmary Leeds Teaching Hospitals NHS TrustLeedsUK

Personalised recommendations